DIA Biosimilars 2013

CROs/Service Providers

Marken expands four facilities

Tuesday, August 28, 2012 12:30 PM

Marken, based in Research Triangle Park, N.C., has opened four expanded branch facilities to meet continued growth.

More... »

Cenduit: Now with Patient Reminders

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »

CRF Health – eCOA Forum

United Drug to acquire pharmacovigilance, market access companies

Tuesday, August 28, 2012 12:21 PM

United Drug, an international provider of healthcare services, will acquire North Carolina-based Drug Safety Alliance for a total of up to $28 million, and North Carolina-based Synopia RX for up to $12 million.

More... »

Leica Biosystems to acquire Aperio

Thursday, August 23, 2012 11:44 AM

An affiliate of Leica Biosystems, an anatomical pathology solutions company, has agreed to acquire Aperio, a provider of ePathology solutions. 

More... »

PRA expands operations in China

Wednesday, August 22, 2012 01:10 PM

PRA, a global CRO, has opened a second office in China to accommodate its expansion in China and the Asia Pacific region.

More... »

PRECOS awarded HTA license, expands PDX drug discovery models

Wednesday, August 22, 2012 11:22 AM

Preclinical Oncology Services (PRECOS), a pre-clinical research and development service provider focused on oncology, has been awarded a license to store and research human tissue samples by the Human Tissue Authority (HTA).

More... »

Cambrex announces significant new supply agreement

Tuesday, August 21, 2012 02:27 PM

Cambrex, a life sciences company based in East Rutherford, N.J., has entered into an non-exclusive agreement to supply an active pharmaceutical ingredient for a customer's phase III program during 2013 and 2014. 

More... »

Almac launches next generation sequencing service for personalized medicine

Tuesday, August 21, 2012 09:10 AM

Global service provider Almac is launching a next generation sequencing (NGS) service to further expand its range of solutions supporting the development of personalized medicine.

More... »

United Drug acquires Bilcare’s clinical trials materials business

Monday, August 20, 2012 11:51 AM

United Drug, an international provider of healthcare services, will acquire the U.K. and U.S. clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited for $61 million. The acquisition is expected to be completed on Aug. 31. Bilcare will retain its clinical supplies business in Asia.

More... »

India CRO market to earn $1B by 2016, says Frost & Sullivan

Monday, August 20, 2012 09:44 AM

The CRO market in India earned revenues of $485 million in 2010-11 and is estimated to cross $1.0 billion in 2016, according to new analysis from Frost & Sullivan, “Strategic Analysis of the Clinical Research Organization Market in India.”

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs